Marijuana Stocks & Public Companies

Stocks & Public Company News

SEC Files Charges Over Alleged MMJ Investment Scam

Wall Street regulators filed civil fraud charges against a company and four people allegedly caught up in a scheme to bilk investors out of nearly a million dollars through a company purported to be a Massachusetts medical cannabis venture. The Securities and Exchange Commission charged that the head of the operation raised $550,000 from investors between 2011 […]

Read More

Week in Review: OH Lawmakers Okay MMJ, Nasdaq says No to MassRoots & MMJ for Vets

By John Schroyer and Omar Sacirbey Ohio lawmakers pass a medical marijuana bill in a bid to undercut a ballot measure, MassRoots’ Nasdaq listing is nixed again, and Congress moves to give military veterans easier access to medical cannabis. Here’s a closer look at several notable developments in the marijuana industry over the past week.

Read More

Nasdaq shoots down MassRoots for stock listing

Denver-based MassRoots, the popular social network for cannabis enthusiasts, failed again to secure a public listing on the Nasdaq, a setback for marijuana companies hoping to trade on a major U.S. stock market. MassRoots said in a press release the Nasdaq linked its decision to the argument that the company, as a pro-marijuana business, could be […]

Read More

FDA Grants U.K. Firm Incentives to Develop Cannabis-Based Drug

U.S. regulators granted GW Pharmaceuticals’ cannabis-based epilepsy drug “orphan” status, enabling the company to receive tax credits and other incentives so it can test the drug on patients with a rare form of the disorder. The U.S. Food and Drug Administration’s decision gives British-based GW the green light to test its Epidiolex medicine for treating […]

Read More

AmeriCann Invests $6.7M in Massachusetts MJ Facilities

AmeriCann, a Denver medical marijuana company, is investing nearly $7 million in a dispensary and a grow facility in two southern coastal Massachusetts towns, according to the Taunton Gazette. The cultivation technology and real estate company is under contract to purchase a nearly 1 million-square-foot site for a medical marijuana grow and processing facility in the […]

Read More

MassRoots Taking Another Stab at Nasdaq Listing

MassRoots, the popular social network for cannabis enthusiasts, is taking another shot at getting listed on the Nasdaq. The Colorado-based company filed an S-1 registration form on Monday with the Securities and Exchange Commission to raise up to $6.5 million by selling shares and warrants – a key part of the process for getting listed on the Nasdaq. […]

Read More

GW Pharmaceuticals Could Make Major Splash in U.S. Cannabis Industry

By Omar Sacirbey A British company that develops cannabis-based medicine is on the verge of a major breakthrough that could ripple across the U.S. marijuana industry. GW Pharmaceuticals will likely seek FDA approval in the fourth quarter of this year to sell an epilepsy drug derived from marijuana, according to an analyst who follows the company.

Read More

Hustler Publisher Invests in Ancillary MMJ Company

The cannabis industry is attracting investors from all walks of life. Including porn. Larry Flynt, the famed publisher of Hustler Magazine, has thrown down $100,000 for 100,000 shares of stock in Pineapple Express, a publicly traded company in Los Angeles that provides consulting, property rentals and technology investments to marijuana businesses. Pineapple Express hired Flynt’s […]

Read More

Study Results Send GW Pharma’s Stock Soaring

A British maker of cannabis-based drugs revealed some sorely needed good news on Monday, announcing that an epilepsy medicine it created has successfully treated a severe form of epilepsy in children, according to Reuters. In a clinical study, GW Pharmaceuticals said its Epidiolex syrup reduced the monthly number of seizures in children with Dravet’s Syndrome by […]

Read More

Oakland Dispensary Shares To Be Publicly Traded

By Omar Sacirbey

Following a brutal 2015 for marijuana stocks, the cannabis investment sector has something to smile about to start the new year. The stock markets will soon welcome a U.S. dispensary to the ranks of the publicly traded: Black Oak Gallery, better known as Blüm Oakland.

Read More

Chart of the Week: Cannabis Stocks End 2015 With Bumps, Bruises

By Becky Olson Last year was a tumultuous one for cannabis stocks, further deterring institutional investors from getting involved in a notoriously high-risk sector. A sampling of 12 stocks analyzed by Marijuana Business Daily started the year off strong, collectively rising about 27% during the first few weeks of 2015.

Read More

Medicine Man Technologies Nears Stock Listing

Medicine Man Technologies, a Colorado-based cannabis consulting firm tied to the family behind two high-profile marijuana stores, received clearance from the Financial Industry Regulatory Authority on Tuesday to become a publicly traded company. Its shares will trade on the over-the-counter markets, possibly as soon as mid-January, according to company founder and chief operating officer Brett Roper. […]

Read More